Various malignancies were reported overexpression of CDC20 and high expression of CDC20 was associated with higher tumor grade in bladder, cervical, colon, endometrial, gastric, liver, ovarian, prostatic, and renal carcinomas (35). This evidence concerns the gene CDC20 and neoplasm.